Title: Perceived Benefits and Barriers of Payer-Manufacturer Post-marketing Outcomes Study Collaborations

Author: Eleanor Olvey Caplan PharmD, PhD1; Katya SvobodaMBA, MPH2; Ryan Coraggio MBA2; Nathan White CPC1; Dana Yi MSN, MBA, RN, GNP, CAIA2; Cheryl del Rosario MBA2; Sam MalikMA, MBA2 1NucleusX Market Access, Atlanta, GA, USA, 2Percipient LLC, Somerville, NJ, USA

Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual International Meeting, June 2nd, 2014, Montreal, QC, Canada

Title: Payer Evidence Requirements for New Drugs: Trends and Impact

Author: Nathan White, CPC, Katya Svoboda, MBA, MPH

Presented at the Academy of Managed Care Pharmacy (AMCP) 26th Annual Meeting and Expo; April 3, 2014; Tampa, FL

Title: Trends in Publication of Comparative Value Assessments for Interventions in Cancer, Diabetes and Cardiovascular Diseases from 2010 to 2012

Authors: Eleanor L. Olvey, PharmD, PhD; Nathan P. White, CPC

Presented at the International Society for Pharmacoeconomic and Outcomes Research (ISPOR) 18th Annual International Meeting; May 22, 2013; New Orleans, LA


Title: Formulary Decision Makers’ Perceptions Regarding Value of Adherence Programs and Associated Outcomes Studies

Authors: Nathan P. White, CPC; Eleanor L. Olvey, PharmD, PhD; Gary Rice, RPh, MS, MBA

Presented at the Academy of Managed Care Pharmacy (AMCP) 25th Annual Meeting and Expo; April 4, 2013; San Diego, CA

Title: The Role of Patient Reported Outcomes in the Payer Evidence Evaluation Process

Author: Nathan P. White, CPC

Presented at the Academy of Managed Care Pharmacy (AMCP) 24th Annual Meeting and Expo; April 8, 2012; San Francisco, CA

 

Webinar
Adherence and Compliance—The Holy Grail of Specialty Therapy Outcomes

Presenters: Gary Rice, RPh, MS, MBA, Diplomat Specialty Pharmacy; Eleanor L. Olvey, PharmD, PhD, NucleusX Market Access
Presented March 1, 2013


View NucleusX Market Access Brochure

imagetext